Almenar-Pérez, E., Sánchez-Fito, T., Ovejero, T., Nathanson, L., & Oltra, E. (2019). Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments. Pharmaceutics.
Citação norma ChicagoAlmenar-Pérez, Eloy, Teresa Sánchez-Fito, Tamara Ovejero, Lubov Nathanson, and Elisa Oltra. "Impact of Polypharmacy On Candidate Biomarker MiRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back On Treatments." Pharmaceutics 2019.
MLA CitationAlmenar-Pérez, Eloy, et al. "Impact of Polypharmacy On Candidate Biomarker MiRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back On Treatments." Pharmaceutics 2019.